Back to Results
First PageMeta Content
Piperazines / Eli Lilly and Company / Organochlorides / Lactams / Tetracycline antibiotics / Atomoxetine / Zopiclone / Adverse effect / Antipsychotic / Chemistry / Organic chemistry / Medicine


Prescriber Update Vol. 35 No. 2 www.medsafe.govt.nz June 2014 ISSN[removed]print)
Add to Reading List

Document Date: 2014-06-05 23:22:00

Open Document

File Size: 2,20 MB

Share Result on Facebook

City

London / /

Company

Pharmaceutical Press / Pfizer New Zealand Ltd. / Sanofi-Aventis New Zealand Limited. / Abbott Laboratories / Eli Lilly and Company / Apotex NZ Ltd. / /

Country

Australia / New Zealand / /

/

Facility

Alert Cook Petite Vital Port / Olanzapine Depot / /

/

IndustryTerm

treatment of benign prostatic hyperplasia / herbal products / early warning communications / dangerous machinery / treatment of Attention-Deficit/Hyperactivity Disorder / media releases / combination products / treatment of post-injection syndrome / treatment of migraine / intramuscular site / online article / treatment of hypertension / /

MedicalCondition

middle insomnia / postinjection delirium/sedation syndrome / seizures / Stevens Johnson Syndrome / Parkinsons Disease / Amoxycillin-Clavulanic Acid-Related Tooth Discoloration / severe hypotension / toxic epidermal necrolysis / pain/body aches / dyspnoea / persistent cough / benign prostatic hyperplasia / psychomotor impairment / cardiac arrest / ataxia and extrapyramidal symptoms / ADHD / SCARs / fever / ataxia hypertension / pain reliever/fever / infection / Post-Injection Syndrome / dystonia / dizziness / depression / tardive dyskinesia / Fibrosis / SCAR / BPH / chest pain / cardiac fibrosis / headache / chronic endocrine disorders / skin rash / mouth ulcers / tremor / syncope / short-term and chronic insomnia / erythema multiforme / breakthrough bleeding / hypersensitivity / especially postural hypotension / Hypotension / Attention-Deficit/Hyperactivity Disorder / ataxia / hypertension / initial insomnia / migraine / pain / renal insufficiency / heart failure / delirium / marked hypotension / cough / syndrome / akathisia / /

MedicalTreatment

complementary medicines / contraception / first aid / complementary medicine / Antibiotics / /

Organization

Ministry of Health Prescriber Update / Centre for Adverse Reactions Monitoring / Medicines and Medical Devices Safety Authority / Centre Adverse Reactions Monitoring / Ministry of Health / Medicines Adverse Reactions Committee / New Zealand Pharmacovigilance Centre / US Food and Drug Administration / /

Person

Enver Yousuf Published / Sonia Varma / Rowan Pollock / Lily Chan / Richard Jaine / Stewart Jessamine / Stevens Johnson / Pharmacovigilance Prescriber / Editorial Team Chris James / Susan Kenyon / Andrea V Govender / Martin Bonne / /

/

Position

Advisor / Principal Clinical Advisor / Group Manager / Director-General / Senior Medical Advisor / Editor / Advisor Product Safety / Medical Advisor / Governor / PhD Principal Technical Specialist Data sheets / Manager Clinical Risk / /

Product

acetaminophen / Allopurinol / amoxicillin / cabergoline / penicillin / Dostinex / Hytrin / doxycycline / Cafergot / Olanzapine / Strattera / Zyprexa / /

Technology

pdf / /

URL

www.fda.gov / www.medsafe.govt.nz/profs/datasheet/z / www.medsafe.govt.nz/profs/Data / www.medsafe.govt.nz/profs / www.medsafe.govt.nz/profs/datasheet/a / www.mhra.gov / www.medsafe.govt.nz/profs/profs.asp / www.medsafe.govt.nz / www.medsafe / www.medsafe.govt.nz/profs/subscribe.asp / www.fda.gov/drugs/drugsafety / www.medsafe.govt.nz/Projects/B2/EWS.asp / www.health.govt.nz/copyright / www.medsafe.govt.nz/profs/PUArticles / /

SocialTag